Financhill
Back

Syros Pharmaceuticals Vs. AbbVie Industry Stock Comparison

Sell
33

SYRS
Syros Pharmaceuticals

Last Price:
0.27
Seasonality Move:
17.91%
Sell
31

ABBV
AbbVie

Last Price:
169.64
Seasonality Move:
4.77%
Sell
33
Syros Pharmaceuticals (SYRS) is a Sell

Is Syros Pharmaceuticals a Buy, Sell or Hold?

  • The current Syros Pharmaceuticals [SYRS] share price is $0.36. The Score for SYRS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • SYRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
AbbVie (ABBV) is a Sell

Is AbbVie a Buy, Sell or Hold?

  • The current AbbVie [ABBV] share price is $170.35. The Score for ABBV is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SYRS Stock Price Chart

What is Syros Pharmaceuticals's stock price today?

  • The Syros Pharmaceuticals share price today is $0.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRS is experiencing selling pressure, which indicates risk of future bearish movement.

ABBV Stock Price Chart

What is AbbVie's stock price today?

  • The AbbVie share price today is $170.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing selling pressure, which indicates risk of future bearish movement.

SYRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 28.2 Sell
Chaikin Money Flow: -25163664 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.72 - 2.72) Sell
Bollinger Bands (100): (1.39 - 5.03) Sell

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.23 Sell
Relative Strength Index (14 RSI): 25.54 Sell
Chaikin Money Flow: -4446578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (182.77 - 201.07) Sell
Bollinger Bands (100): (176.81 - 198.55) Sell

SYRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.36 Sell
20-day SMA: 2.29 Sell
50-day SMA: 2.04 Sell
200-day SMA: 4.56 Sell
8-day EMA: 2.15 Sell
20-day EMA: 2.24 Sell
50-day EMA: 2.37 Sell
200-day EMA: 3.78 Sell

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 189.9 Sell
20-day SMA: 191.36 Sell
50-day SMA: 193.24 Sell
200-day SMA: 178.8 Sell
8-day EMA: 184.7 Sell
20-day EMA: 190.24 Sell
50-day EMA: 191.21 Sell
200-day EMA: 179.26 Sell

Syros Pharmaceuticals Earnings Growth & SYRS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and a decrease next year of $1.03 per share.

AbbVie Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.17 per share.

Syros Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

AbbVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):